Determining Patterns In Trial Experiences of Diabetic Neuropathy Patients

Power Life Sciences Inc.500 enrolled

Overview

Historically, participation in clinical studies is highly skewed towards particular demographic groups of people. This study will invite several participants to gather a wide range of information on clinical trial experiences for diabetic neuropathy patients. The aim of the study is to identify the factors that limit the ability of a person to enroll in, as well as complete a clinical trial for treatment of diabetic neuropathy. The data collected from this study will help improve future outcomes for all diabetic neuropathy patients as well as those in under-represented demographic groups.

Study Type

OBSERVATIONAL

Enrollment

500

Conditions

Diabetic Neuropathies Diabetic Neuropathy Peripheral

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patient plans to participate in an interventional clinical trial for the condition of diabetic neuropathy * Patient has been diagnosed with a type of diabetic neuropathy * Patient is a minimum of 18 years of age * Patient has access to a home internet connection in order to provide regular updates through the course of the study Exclusion Criteria: * Patient is not able to provide consistent digital updates as per study requirements * Patient does not complete or agree to terms outlined in the Informed Consent Form * Patient has an ECOG score of 4 or higher

Outcomes

Primary Outcomes

Number of patients who decide to enroll in an diabetic neuropathy clinical trial

Time frame: 3 months

Rate of patients who remain in diabetic neuropathy clinical trial to trial completion

Time frame: 12 months